FEDERAL INTERESTS AND POLICIES RELATED TO ARTIFICIAL INTERNAL ORGAN DEVELOPMENT.LEVY RI.1977; CARDIOVASCUL. DIS.; U.S.A.; DA. 1977; VOL. 4; NO 2; PP. 105-110Article

PROGRESS TOWARD PREVENTION OF CARDIOVASCULAR DISEASELEVY RI.1979; CIRCULATION; USA; DA. 1979; VOL. 60; NO 7; PP. 1555-1559Article

THE EFFECT OF HYPOLIPIDEMIC DRUGS ON PLASMA LIPOPROTEINS.LEVY RI.1977; ANNU. REV. PHARMACOL. TOXICOL.; U.S.A.; DA. 1977; VOL. 17; PP. 499-510; BIBL. 2 P.Article

DRUG THERAPY OF HYPERLIPOPROTEINEMIA.LEVY RI.1976; J.A.M.A.; U.S.A.; DA. 1976; VOL. 235; NO 21; PP. 2334-2336; BIBL. 8 REF.Article

HIGH DENSITY LIPOPROTEINS, 1978. AN OVERVIEWLEVY RI.1978; LIPIDS; USA; DA. 1978; VOL. 13; NO 12; PP. 911-913Article

CHOLESTEROL, LIPOPROTEINS, APOPROTEINS, AND HEART DISEASE: PRESENT STATUS AND FUTURE PROSPECTSLEVY RI.1981; CLIN. CHEM.; ISSN 0009-9147; USA; DA. 1981; VOL. 27; NO 5; PP. 653-662; BIBL. 10 REF.Article

LIPOPROTEIN METABOLISM.EISENBERG S; LEVY RI.1975; ADV. LIPID RES.; U.S.A.; DA. 1975; VOL. 13; PP. 1-89; BIBL. 9 P. 1/2Article

INTERCONVERSIONS OF APOLIPOPROTEIN FRAGMENTS = INTERCONVERSIONS DES FRAGMENTS D'APOLIPOPROTEINESBLUM CB; LEVY RI.1975; ANNU. REV. MED.; U.S.A.; DA. 1975; VOL. 26; PP. 365-371; BIBL. 1P. 1/2Article

LIPOPROTEIN APOPROTEIN METABOLISMSCHAEFER EJ; EISENBERG S; LEVY RI et al.1978; J. LIPID. RES.; USA; DA. 1978; VOL. 19; NO 6; PP. 667-687; BIBL. 153 REF.Article

PRIMARY TYPE V HYPERLIPOPROTEINEMIA. A DESCRIPTIVE STUDY IN 32 FAMILIES.GREENBERG BH; BLACKWELDER WC; LEVY RI et al.1977; ANN. INTERN. MED.; U.S.A.; DA. 1977; VOL. 87; NO 5; PP. 526-534; BIBL. 1 P. 1/2Article

SELECTIVE MEASUREMENT OF TWO LIPASE ACTIVITIES IN POSTHERAPIN PLASMA FROM NORMAL SUBJECTS AND PATIENTS WITH HYPERLIPOPROTEINEMIA = MESURE SELECTIVE DE 2 ACTIVITES LIPASIQUES DANS LE PLASMA POST-HEPARINE DE SUJETS NORMAUX ET DE MALADES AVEC UNE HYPERLIPOPROTEINEMIEKRAUSS RM; LEVY RI; FREDRICKSON DS et al.1974; J. CLIN. INVEST.; U.S.A.; DA. 1974; VOL. 54; NO 5; PP. 1107-1124; BIBL. 2 P. 1/2Article

NEONATAL DIAGNOSIS OF FAMILIAL TYPE-II HYPERLIPOPROTEINAEMIA = DIAGNOSTIC NEO-NATAL D'HYPERLIPOPROTEINEMIE FAMILIALE DU TYPE IIKWITEROVICH PO JR; LEVY RI; FREDRICKSON DS et al.1973; LANCET,; G.B.; DA. 1973; NO 7795; PP. 118-122; BIBL. 27REF.Serial Issue

THE BIOCHEMICAL, CLINICAL, AND GENETIC FEATURES OF TYPE III HYPERLIPOPROTEINEMIA = ASPECTS GENETIQUES, CLINIQUES ET BIOCHIMIQUES DE L'HYPERLIPOPROTEINEMIE DE TYPE IIIMORGANROTH J; LEVY RI; FREDRICKSON DS et al.1975; ANN. INTERN. MED.; U.S.A.; DA. 1975; VOL. 82; NO 2; PP. 158-174; BIBL. 29 REF.Article

TYPE III HYPERLIPOPROTEINEMIA: AN ANALYSIS OF TWO CONTEMPORARY DEFINITIONS = HYPERLIPOPROTEINEMIE DE TYPE III: ANALYSE DE DEUX DEFINITIONS CONTEMPORAINESFREDRICKSON DS; MORGANROTH J; LEVY RI et al.1975; ANN. INTERN. MED.; U.S.A.; DA. 1975; VOL. 82; NO 2; PP. 150-157; BIBL. 16REF.Article

THE KINETIC PROPERTIES OF VERY LOW DENSITY LIPOPROTEIN TRIGLYCERIDE IN TYPE III HYPERLIPOPROTEINEMIA = LES PROPRIETES CINETIQUES DES TRIGLYCERIDES DES LIPOPROTEINES DE FAIBLE DENSITE DANS L'HYPERLIPOPROTEINEMIE DE TYPE IIIQUARFORDT SH; LEVY RI; FREDERICKSON DS et al.1973; BIOCHIM. BIOPHYS. ACTA; PAYS-BAS; DA. 1973; VOL. 296; NO 3; PP. 572-576; BIBL. 18 REF.Serial Issue

CURRENT STATUS OF THE ROLE OF DIETARY TREATMENT IN THE PREVENTION AND MANAGEMENT OF CORONARY HEART DISEASERIFKIND BM; GOOR RS; LEVY RI et al.1979; MED. CLIN. N. AMER.; USA; DA. 1979; VOL. 63; NO 5; PP. 911-925; BIBL. 38 REF.Article

POSITION ON PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA)LEVY RI; JESSE MJ; MOCK MB et al.1979; CIRCULATION; USA; DA. 1979; VOL. 59; NO 3; PP. 613Article

STUDIES ON THE PROTEIN DEFECT IN TANGIER DISEASE. ISOLATION AND CHARACTERIZATION OF AN ABNORMAL HIGH DENSITY LIPOPROTEIN = RECHERCHES SUR LE DEFICIT PROTEIQUE DANS LA MALADIE DE TANGER. ISOLEMENT ET CARACTERISATION D'UNE LIPOPROTEINE DE DENSITE ANORMALEMENT ELEVEELUX SE; LEVY RI; GOTTO AM et al.1972; J. CLIN. INVEST.; U.S.A.; DA. 1972; VOL. 51; NO 10; PP. 2505-2519; BIBL. 63REF.Serial Issue

SERUM CHLORIDE ANALYSIS, BROMIDE DETECTION AND THE DIAGNOSIS OF BROMISMWENK RE; LUSTGARTEN JA; PAPPAS NJ et al.1976; AMER. J. CLIN. PATHOL.; U.S.A.; DA. 1976; VOL. 65; NO 1; PP. 49-57; BIBL. 14 REF.Article

RESTING LEVELS OF BLOOD FIBRINOLYSIS IN HYPERLIPOPROTEINEMIA = LES TAUX AU REPOS DE LA FIBRINOLYSE DU SANG DANS L'HYPERLIPOPROTEINEMIEBRAKMAN P; ASTRUP T; LEVY RI et al.1974; J. APPL. PHYSIOL.; U.S.A.; DA. 1974; VOL. 36; NO 4; PP. 430-433; BIBL. 27REF.Article

CHANGES IN PLASMA LIPIDS AND LIPOPROTEINS AFTER A MODIFIED FAT DIETERNST N; BOWEN P; FISCHER M et al.1980; LANCET; GBR; DA. 1980; NO 8186; PP. 111-112; BIBL. 7 REF.Article

LIPID, GLUCOSE AND INSULIN INTERRELATIONSHIPS IN NORMAL PREDIABETIC AND CHEMICAL DIABETIC SUBJECTS.KYNER JL; LEVY RI; SOELDNER JS et al.1976; J. LAB. CLIN. MED.; U.S.A.; DA. 1976; VOL. 88; NO 3; PP. 345-358; BIBL. 1 P. 1/2Article

SOLID PHASE RADIOIMMUNOASSAY OF APOLIPOPROTEIN B(APO B) IN NORMAL HUMAN PLASMA.THOMPSON GR; BIRNBAUMER ME; LEVY RI et al.1976; ATHEROSCLEROSIS; NETHERL.; DA. 1976; VOL. 24; NO 1-2; PP. 107-118; BIBL. 1 P.Article

HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA. A POSSIBLE BIOCHEMICAL EXPLANATION OF CLINICAL HETEROGENEITY. = HYPERCHOLESTEROLEMIE FAMILIALE HOMOZYGOTE. UNE EXPLICATION BIOCHIMIQUE POSSIBLE DE L'HETEROGENEITE CLINIQUEBRESLOW JL; SPAULDING DR; LUX SE et al.1975; NEW ENGL. J. MED.; U.S.A.; DA. 1975; VOL. 293; NO 18; PP. 900-903; BIBL. 21 REF.Article

PSEUDOHOMOZYGOUS TYPE II HYPERLIPOPROTEINEMIA = HYPERLIPOPROTEINEMIE DE TYPE II PSEUDO-HOMOZYGOTEMORGANROTH J; LEVY RI; MCMAHON AE et al.1974; J. PEDIATR.; U.S.A.; DA. 1974; VOL. 85; NO 5; PP. 639-643; BIBL. 10REF.Article